XML 113 R114.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator for earnings (loss) per share calculation:                      
Income (loss) from continuing operations $ 1,744 $ 1,529 $ 1,931 $ 1,427 $ (422) $ 1,390 $ (2,562) $ 998 $ 6,631 $ (596) $ 6,631
Income allocated to participating securities                 (5) (3) (24)
Net (income) loss attributable to noncontrolling interests                 3 2 (1)
Income (loss) from continuing operations attributable to CVS Health                 $ 6,629 $ (597) $ 6,606
Denominator for earnings (loss) per share calculation:                      
Weighted average shares, basic (in shares)                 1,301 1,044 1,020
Effect of dilutive securities (in shares)                 4 0 4
Weighted average shares, diluted (in shares)                 1,305 1,044 1,024
Earnings (loss) per share from continuing operations:                      
Earnings (loss) per share from continuing operations, basic (USD per share) $ 1.34 $ 1.17 $ 1.49 $ 1.09 $ (0.37) $ 1.36 $ (2.52) $ 0.98 $ 5.10 $ (0.57) $ 6.48
Earnings (loss) per share from continuing operations, diluted (USD per share) $ 1.33 $ 1.17 $ 1.49 $ 1.09 $ (0.37) $ 1.36 $ (2.52) $ 0.98 $ 5.08 $ (0.57) $ 6.45
Employee Stock Option                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of EPS (in shares)                 17 13 10
Common Equivalent Shares                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of EPS (in shares)                   3